Malta - English - Medicines Authority

bio products laboratory limited dagger lane, elstree hertfordshire, wd6 3bx, united kingdom - factor viii, human - powder and solvent for solution for injection - factor viii, human 25 iu/ml - antihemorrhagics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - factor viii; von willebrand factor - powder and solvent for solution for injection - 500unit ; 1000unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

germax sdn. bhd. - factor viii fraction, dried -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

germax sdn. bhd. - factor viii fraction, dried -

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 1000 [iu]; von willebrand's factor : ristocetin cofactor 2000 [iu] - injection with diluent - 1000 iu - active: dried factor viii fraction 1000 [iu] von willebrand's factor : ristocetin cofactor 2000 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

New Zealand - English - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - factor viii, human 250 [iu] (factor viii ex nz) - injection with diluent - 250 iu/10ml - active: factor viii, human 250 [iu] (factor viii ex nz) excipient: chloride citrate sodium sucrose trometamol water for injection

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 1000 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 500 [iu]; von willebrand's factor : ristocetin cofactor 1000 [iu] - injection with diluent - 500 iu - active: dried factor viii fraction 500 [iu] von willebrand's factor : ristocetin cofactor 1000 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - factor viii (human) - powder for solution for injection - factor viii (human) 250 iu/vial - coagulation factor viii - coagulation factor viii - for the treatment of classical hemophilia (hemophilia a) in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor viii . koate-dvi provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia.